Virtual-reality–based relaxation significantly reduced anxiety symptoms in patients with Generalized Anxiety Disorder compared to standard relaxation.
Malbos et al., 2025 – Journal of Clinical Medicine
Read the study 
SWISS TECHNOLOGY
Alliance of Neuroscience and Immersion
10 to 30-minute clinical VR protocols that restore calm, focus and energy at every step of the care pathway.
Clinical VR protocols against anxiety.
Become a clinical or research partner
Request accessExclusive conditions for early clinical partners.
Co-design of protocols with your clinical team.
Scientific support and joint publication.
Our solution
Precise virtual reality for anxiety
Alsensia designs precisely orchestrated 10 to 30-minute therapeutic protocols, drawing from scientifically validated techniques. Our solution targets anxiety and anxious disorders to restore calm, mental clarity and energy - at every step of the care pathway.
Built for clinicians. Built for patients. For the moments that matter.
Medical professionals
Hospitals · Clinics · Independent practitioners
Ready-to-deploy, non-pharmacological protocols for psychiatrists, psychologists and mental health teams - in consultation rooms, clinics and inpatient settings.
Patient journey
Pre-op anxiety · Long-stay · Palliative care
From pre-anaesthesia anxiety to long-stay companionship, Alsensia supports the critical moments where emotional regulation changes the quality of care.
Complementary practitioners
Hypnotherapists · Sophrologists · Neurofeedback
For non-medical practitioners: an immersive way to deepen inductions and steer sessions on real signals, extending hypnosis, sophrology and biofeedback work.
We are looking for clinical and research partners to co-design the next generation of VR for anxiety.
A clinical-grade system, built for real-world care
Immersive virtual reality, artificial intelligence and real-time biofeedback - a therapeutic environment that continuously adapts to the patient state.
Built on scientifically validated protocols and deployable across a wide range of care settings.
Virtual reality has demonstrated superior outcomes compared to traditional therapeutic approaches.
What our users say
An experience that speaks for itself
Feedback gathered from 55 users across 7 partner organizations: ophthalmology clinics and Health Tech Global Summit 2026.
feel an immediate relaxation effect
Average score 4/5 · n=55
report improved focus
Corporate · average score 4/5
satisfied with the overall experience
n=55
Detailed scores Combined averages · n=55
Ease of use
Comfort & immersion
In their own words
An extraordinary experience.
Very positive - lets you recharge quickly.
Even with a lot of background noise, I really managed to disconnect and calm down.
Truly excellent - I feel very relaxed. I highly recommend it.
A great idea - it lets you take time to relax in an often stressful environment.
Genuinely relaxing!
Frequently asked questions
What is Alsensia?
Alsensia is a Swiss company offering immersive virtual reality for anxiety management. Short, substance-free protocols (10 to 30 minutes), designed by neuroscientists and psychologists, help guide people into a calmer, regulated state.
Who is Alsensia for?
For clinics and hospitals, mental-health professionals (psychiatrists, psychologists) and complementary practitioners such as hypnotherapists, sophrologists and biofeedback or neurofeedback practitioners.
How long is a session?
Each protocol lasts 10 to 30 minutes and can be used to open, deepen or close a session.
Is Alsensia a medical device or a treatment?
No. Alsensia is a substance-free tool used alongside professional care. It is not a certified medical device and does not replace medical advice, diagnosis or treatment.
How does the biofeedback work?
An optional biofeedback module (currently a prototype, open to selected partners) reads signals such as heart rate, heart-rate variability, breathing and skin response in real time to make regulation visible during the session.
Where is Alsensia based?
Alsensia is based at EPFL Innovation Park in Lausanne, Switzerland.
Follow Alsensia’s progress
Occasional updates from our team: product milestones, clinical progress and perspectives on virtual reality for anxiety. For our partners, clients and investors.
Core team
The founding team
We are shaping the new era of Neuro-Wellbeing
Leadership & Founders
Co‑founder & CEO
Gaëlle Rocher
Over 10 years of MedTech business development. Owns commercial strategy, partnerships, fundraising and go-to-market in regulated environments.
Co‑founder & CTO
Johan Rocher
Over 10 years in software architecture, electronics and hardware-software integration for high-reliability medical devices. Owns product, technology and the science roadmap, including the proprietary biofeedback wearable.
Functional Teams
Commercial Development
Customer Lead
Antoine Badie
MedTech sales and e-commerce background, Master in Business Engineering. Runs early client deployment and day-to-day account work in the wellness phase.
Scientific Development
Cyberdelics Expert · Freelance
Giulia Brizzi, PhD
Recognised reference in VR-induced altered states. Her work (Brizzi et al., 2025) underpins the scientific foundation of the PAT‑VR programme. Steers the scientific narrative and publications agenda.
Principal Scientist
Matthieu Beaugrand, PhD
Neuroscientist, 5+ years in neuropsychology and behavioural research. Leads protocol design and the STE induction architecture (Embodiment, Disembodiment, Awe) for the Innosuisse programme.
Technology Development
Biomedical Engineer
Audrey Ménaësse
5+ years in MedTech R&D with a life-sciences and regulatory specialisation. Responsible for scientific coherence between protocol claims and hardware, and for alignment with EU MDR, IEC 62304 and ISO 13485.
VR Engineer
Nathanaël Vianin
ECAL graduate, expert in 3D design and game development. Owns the visual language of our immersive experiences and the scene engineering across the protocol library.
VR Engineer · Freelance
Huizi Yang
10+ years of software engineering experience, Unreal Engine and Meta SDK expert. Owns the runtime, Meta Quest integrations and the engineering pipeline that ships scientific protocols as VR sessions.
Advisors
Advisors
Dr Catherine Duffour, MD
MD, psychiatrist & psychotherapist · Author of “Kétamine, Conscience, Thérapie” (2025) · Board member, Fondation CMH
Advisors
Patrick Santilli
FSP psychologist · Founder of Lively Up Sàrl
Advisors
Christophe Faucherand
Product Leader & Chief Product Officer · Product strategy, AI & platform products
Advisors
Hervé Duffour
MedTech & medical-imaging executive · 25+ years in radiology devices (Philips, Bracco)
Ready to bring Alsensia to your space?
Request accessExclusive conditions for early clinical partners.